Efficacy and Safety of Injectable Dulaglutide 1.5 mg Among Type 2 Diabetes Patients in Clinics at King Saud Medical City, Riyadh, Saudi Arabia

• Main Authors: Mashael Saad Albargawi (Author), Rawan Naser Alharbi (Author), Mohammad Abbas Alajlani (Author), Ibtihal Abdulwarith Abdulaal (Author), Lina Othman Aldakhil (Author)
• Format: Book
• Published: Springer, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Type 2 diabetes mellitus is the most common type of diabetes, characterized by varying degrees of insulin resistance and diminishing beta-cell function, which increases the risk of macrovascular and microvascular complications. Dulaglutide is a long-acting glucagon-like peptide...